-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) announces publication of Efficacy and Safety of Iloperidone in Bipolar Mania
-
-
-
-
-
-
-
FDA Accepts and Grants Priority Review of Vanda's Applications for HETLIOZĀ® (tasimelteon) in the Treatment of Smith-Magenis Syndrome
-
-
-
-
-
-
-
FDA Accepts HETLIOZĀ® (tasimelteon) Supplemental New Drug Application for Review in the Treatment of Jet Lag Disorder
-
-
-
-
-
12,341 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All